Latest Breaking News On - Graduate biomedical sciences - Page 1 : vimarsana.com

Assistant/Associate Professor, New York University Grossman School of Medicine job with NYU Langone Health

Assistant/Associate Professor, New York University Grossman School of Medicine job in New York (US) with NYU Langone Health. Apply Today.

Rethinking 'healthy' to support structure-function claims

Scientists and federal agencies should redefine what it means to be healthy to substantiate structure-function claims for nutraceuticals, according to a perspective published in the Journal of Dietary Supplements.

Rethinking 'healthy' to support structure-function claims

Scientists and federal agencies should redefine what it means to be healthy to substantiate structure-function claims for nutraceuticals, according to a perspective published in the Journal of Dietary Supplements.

CureMatch Welcomes Kimary Kulig, PhD, MPH to Advisory Board

NYU Grossman School of Medicine and Sarah Lawrence College Launch Graduate Genomics Degree Program

/PRNewswire/ -- NYU Grossman School of Medicine's Vilcek Institute of Graduate Biomedical Sciences and Sarah Lawrence College today announced the launch of a...

NYU Grossman School of Medicine and Sarah Lawrence College Launch Graduate Genomics Degree Program

What is the 'Hippocratic oath,' and who was Hippocrates?

Hippocrates was a physician who lived in ancient Greece and is credited with writing a code of ethics called the Hippocratic oath.

OKYO Pharma LTD: OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease

Monday, November 14th @ 8 am ET, registration details below NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Ltd (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology bio-pharmaceutical

Investegate |OKYO Pharma LTD Announcements | OKYO Pharma LTD: OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease

Investegate announcements from OKYO Pharma LTD, OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease

OKYO Pharma Hosting Key Opinion Leader Event Introducing

Monday, November 14th @ 8 am ET, registration details below NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Ltd (Nasdaq: OKYO; LSE: OKYO)...